Abvance Therapeutics
Phase 1Develops targeted immunotherapies for cancer using antibody-based platforms.
Founded
2020
Focus
OncologyImmunology
About
Develops targeted immunotherapies for cancer using antibody-based platforms.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Glucagon + Insulin | Type 1 Diabetes Mellitus With Hypoglycemia | Phase 1 |
Funding History
3Total raised: $35M
Series A$25MUndisclosedMar 15, 2023
Seed$5MUndisclosedJun 15, 2021
Seed$5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile